share_log

Morgan Stanley Maintains Overweight on Pharvaris, Maintains $34 Price Target

Moomoo 24/7 ·  Apr 22 13:28

Morgan Stanley analyst Matthew Harrison maintains Pharvaris (NASDAQ:PHVS) with a Overweight and maintains $34 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment